NK Cell-Based Glioblastoma Immunotherapy

NK Cell-Based Glioblastoma Immunotherapy

Glioblastoma (GB) is the most aggressive and most common malignant primary brain tumor diagnosed in adults. GB shows a poor prognosis and, unfortunately, current therapies are unable to improve its clinical outcome, imposing the need for innovative therapeutic approaches. The main reason for the poo...

Full description

Bibliographic Details
Main Authors: Irene Golán, Laura Rodríguez de la Fuente, Jose A. Costoya
Format: Article
Language:English
Published: MDPI AG 2018-12-01
Series:Cancers
Subjects:
brain tumor
malignant gliomas
glioblastoma
NK cells
immunotherapy
Online Access:https://www.mdpi.com/2072-6694/10/12/522

Internet

https://www.mdpi.com/2072-6694/10/12/522

Similar Items